Publication
Title
New-generation drug-eluting stents : focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent
Author
Abstract
Compared to bare metal stent angioplasty, first-generation drug-eluting stents (DES) have markedly reduced the incidence of in-stent restenosis. However, given the increased concerns over late and very late stent thrombosis, newer-generation DES were developed. To date, these DES have virtually replaced the use of first-generation DES worldwide. In this review article, we carefully consider the pre-clinical and clinical trials that have been performed with currently available, european conformity-marked and Food and Drug Administration-approved new-generation Resolute (R) and Xience V (R) DES. (J Interven Cardiol 2013;26:278-286)
Language
English
Source (journal)
Journal of interventional cardiology. - Mount Kisco, N.Y.
Publication
Mount Kisco, N.Y. : 2013
ISSN
0896-4327
Volume/pages
26:3(2013), p. 278-286
ISI
000320173700010
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 04.09.2013
Last edited 02.08.2017
To cite this reference